Losartan Potassium Tablet, Film Coated
Product Images NDC 68071-5040

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-5040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5040 3)

Label for Losartan Potassium 50 mg oral film-coated tablets from NuCare Pharmaceuticals, Inc. The label indicates a package size of 30 tablets with Rx only restriction. It includes multiple barcodes, NDC 68071-5040-3, and instructions to see the manufacturer's label for a full list of ingredients. The label also notes storage temperature and safety warnings.*

FDA Label Image

Figure1 (Losartan Fig1)

A line graph comparing the percentage of patients with the primary endpoint over a study period of up to 66 months between Atenolol (dotted line) and Losartan Potassium (solid line). The graph shows adjusted risk reduction with statistical values noted.*

FDA Label Image

Figure2 (Losartan Fig2)

A line graph comparing the percentage of patients experiencing fatal or non-fatal strokes over 66 months of study between Atenolol and Losartan Potassium. The graph shows adjusted risk reduction of 25% with Losartan Potassium, with a p-value of 0.001.*

FDA Label Image

Figure 3 (Losartan Fig3)

A forest plot chart titled 'Primary Endpoint Events within Demographic Subgroups' comparing event rates between Losartan Potassium and Atenolol. The chart presents hazard ratios with 95% confidence intervals across subgroups by age, gender, race, ischemic heart disease, diabetes, and cardiovascular disease history, for primary composite and stroke (fatal/non-fatal) events.*

FDA Label Image

Figure-4 (Losartan Fig4)

A line graph comparing the percentage of patients with events over 48 months for Losartan Potassium and placebo groups. The graph includes a risk reduction of 16.1% and a p-value of 0.022, indicating statistical significance.*

FDA Label Image

Chemical Structure (Losartan Str)

Chemical structure of Losartan Potassium, a small molecule compound depicted with rings, chlorine, nitrogen, and potassium ion (K+). This structure represents the active ingredient in the film-coated tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.